Effect of cytokines on the expression of cell adhesion molecule and on the adhesion of melanoma cells to endothelial cells.

por Kim, S. J., Kim, N. S., Lee, J. L.
Publicado 1993

An aberrant nuclear localization of E-cadherin is a potent inhibitor of Wnt/β-catenin-elicited promotion of the cancer stem cell phenotype

por Su, Y-J, Chang, Y-W, Lin, W-H, Liang, C-L, Lee, J-L
Publicado 2015

Phase II study of pemetrexed in combination with cisplatin in patients with advanced urothelial cancer: the PECULIAR study (KCSG 10–17)

por Choi, Y J, Lee, S H, Lee, J-L, Ahn, J-H, Lee, K-H, You, D, Hong, B, Hong, J H, Ahn, H
Publicado 2015

Anti-VEGF therapy in mRCC: differences between Asian and non-Asian patients

por Wang, Y, Choueiri, T K, Lee, J-L, Tan, M-H, Rha, S Y, North, S A, Kollmannsberger, C K, McDermott, D F, Heng, D Y C
Publicado 2014

Safety and efficacy of cobimetinib plus atezolizumab in patients with solid tumors: a phase II, open-label, multicenter, multicohort study

por Sherman, E., Lee, J.L., Debruyne, P.R., Keam, B., Shin, S.J., Gramza, A., Caro, I., Amin, R., Shah, K., Yan, Y., Huddart, R., Powles, T.
Publicado 2023

ATLAS trial of adjuvant axitinib in patients with renal cell carcinoma: subgroup analyses with focus on axitinib dosing and racial groups

por Quinn, D.I., Ng, C.F., Grande, E., Kwon, T.G., Linke, R., Lee, J.-L., Rosbrook, B., Thakur, M.N., Eto, M., Gross-Goupil, M.
Publicado 2021

Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum

por Yoon, D H, Ryu, M-H, Park, Y S, Lee, H J, Lee, C, Ryoo, B-Y, Lee, J-L, Chang, H-M, Kim, T W, Kang, Y-K
Publicado 2012

Phase II and UGT1A1 genotype study of irinotecan dose escalation as salvage therapy for advanced gastric cancer

por Jo, J-C, Lee, J-L, Ryu, M-H, Chang, H M, Kim, M, Lee, H J, Kim, H-S, Shin, J-G, Kim, T-W, Kang, Y-K
Publicado 2012

Gemcitabine–oxaliplatin plus prednisolone is active in patients with castration-resistant prostate cancer for whom docetaxel-based chemotherapy failed

por Lee, J-L, Ahn, J-H, Choi, M K, Kim, Y, Hong, S-W, Lee, K-H, Jeong, I-G, Song, C, Hong, B-S, Hong, J H, Ahn, H
Publicado 2014

Phase II study of S-1 combined with oxaliplatin as therapy for patients with metastatic biliary tract cancer: influence of the CYP2A6 polymorphism on pharmacokinetics and clinical...

por Kim, K-p, Jang, G, Hong, Y S, Lim, H-S, Bae, K-s, Kim, H-S, Lee, S S, Shin, J-G, Lee, J-L, Ryu, M-H, Chang, H-M, Kang, Y-K, Kim, T W
Publicado 2011

A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer

por Yoo, C, Hwang, J Y, Kim, J-E, Kim, T W, Lee, J S, Park, D H, Lee, S S, Seo, D W, Lee, S K, Kim, M-H, Han, D J, Kim, S C, Lee, J-L
Publicado 2009

Phase II study of a trastuzumab biosimilar in combination with paclitaxel for HER2-positive recurrent or metastatic urothelial carcinoma: KCSG GU18-18

por Kim, M., Lee, J.L., Shin, S.J., Bae, W.K., Lee, H.J., Byun, J.H., Choi, Y.J., Youk, J., Ock, C.Y., Kim, S., Song, H., Park, K.H., Keam, B.
Publicado 2023

Axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: results from the phase III, randomized ATLAS trial

por Gross-Goupil, M, Kwon, T G, Eto, M, Ye, D, Miyake, H, Seo, S I, Byun, S -S, Lee, J L, Master, V, Jin, J, DeBenedetto, R, Linke, R, Casey, M, Rosbrook, B, Lechuga, M, Valota, O, Grande, E, Quinn, D I
Publicado 2018

A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer

por Lee, J-L, Kang, Y-K, Kang, H J, Lee, K-H, Zang, D Y, Ryoo, B-Y, Kim, J G, Park, S R, Kang, W K, Shin, D B, Ryu, M-H, Chang, H M, Kim, T-W, Baek, J H, Min, Y J
Publicado 2008

Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2...

por Kang, Y-K, Chang, H-M, Yook, J H, Ryu, M-H, Park, I, Min, Y J, Zang, D Y, Kim, G Y, Yang, D H, Jang, S J, Park, Y S, Lee, J-L, Kim, T W, Oh, S T, Park, B K, Jung, H-Y, Kim, B S
Publicado 2013

Digital intervention increases influenza vaccination rates for people with diabetes in a decentralized randomized trial

por Lee, J. L., Foschini, L., Kumar, S., Juusola, J., Liska, J., Mercer, M., Tai, C., Buzzetti, R., Clement, M., Cos, X., Ji, L., Kanumilli, N., Kerr, D., Montanya, E., Müller-Wieland, D., Ostenson, C. G., Skolnik, N., Woo, V., Burlet, N., Greenberg, M., Samson, S. I.
Publicado 2021

Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up

por Fradet, Y, Bellmunt, J, Vaughn, D J, Lee, J L, Fong, L, Vogelzang, N J, Climent, M A, Petrylak, D P, Choueiri, T K, Necchi, A, Gerritsen, W, Gurney, H, Quinn, D I, Culine, S, Sternberg, C N, Nam, K, Frenkl, T L, Perini, R F, de Wit, R, Bajorin, D F
Publicado 2019

First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC

por Ko, J J, Choueiri, T K, Rini, B I, Lee, J-L, Kroeger, N, Srinivas, S, Harshman, L C, Knox, J J, Bjarnason, G A, MacKenzie, M J, Wood, L, Vaishampayan, U N, Agarwal, N, Pal, S K, Tan, M-H, Rha, S Y, Yuasa, T, Donskov, F, Bamias, A, Heng, D Y C
Publicado 2014

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with renal cell carcinoma

por Kanesvaran, R., Porta, C., Wong, A., Powles, T., Ng, Q.S., Schmidinger, M., Ye, D., Malhotra, H., Miura, Y., Lee, J.L., Chong, F.L.T., Pu, Y.-S., Yen, C.-C., Saad, M., Lee, H.J., Kitamura, H., Bhattacharyya, G.S., Curigliano, G., Poon, E., Choo, S.P., Peters, S., Lim, E., Yoshino, T., Pentheroudakis, G.
Publicado 2021

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with prostate cancer

por Kanesvaran, R., Castro, E., Wong, A., Fizazi, K., Chua, M.L.K., Zhu, Y., Malhotra, H., Miura, Y., Lee, J.L., Chong, F.L.T., Pu, Y.-S., Yen, C.-C., Saad, M., Lee, H.J., Kitamura, H., Prabhash, K., Zou, Q., Curigliano, G., Poon, E., Choo, S.P., Peters, S., Lim, E., Yoshino, T., Pentheroudakis, G.
Publicado 2022